Sunday, November 22, 2026

Nobel Prize 2025: A breakthrough in immune system research

Date:

Image count1 / 7
CNBCTV18 on Google

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi have been awarded the Nobel Prize in Physiology or Medicine 2025 for their discoveries concerning peripheral immune tolerance. The laureates identified the immune system’s “security guards” — the regulatory T cells — laying the foundation for a new field of research and opening new frontiers for medical treatments.

Image count2 / 7
CNBCTV18 on Google

Understanding the Immune System | The immune system must differentiate between “self” (non-infected cells) and “non-self” (infected or foreign cells). If it fails to do so, it can attack the body’s own tissues, leading to autoimmune diseases. T cells are a category of immune cells that include helper T cells, killer T cells, and regulatory T cells. Helper T cells play a critical role in defense by monitoring for microbes. When they detect a pathogen, they alert other immune cells to initiate an attack. Killer T cells remove cells infected by viruses or pathogens and also attack tumor cells. These T cells have special proteins called T-cell receptors on their surface, which act like sensors, scanning other cells for anomalies and signaling other immune cells when the body is under threat. (Image: Canva)

Image count3 / 7
CNBCTV18 on Google

The Enigma of Autoimmunity | For decades, scientists believed T cells were key defenders against infections and cancers. However, it remained unclear how the immune system could attack invaders without harming the body itself. While central tolerance in the thymus—the organ behind the breastbone—was known to train T cells to distinguish self from non-self, it did not explain why autoimmune diseases could still develop later in life. T cells originate in the bone marrow and travel to the thymus to mature, learning to differentiate between self and foreign cells. Yet, some harmful T cells seemed to escape this process, and the mechanism for controlling them remained unknown. (Image: Canva)

Image count4 / 7
CNBCTV18 on Google

Discovery of Regulatory T Cells | In the 1980s, Shimon Sakaguchi discovered a new class of T cells, later named regulatory T cells. Experiments in mice showed that the thymus could train the immune system within the first three days after birth. However, mice whose thymus was removed after three days developed autoimmune diseases, showing that harmful T cells had entered the bloodstream. Sakaguchi’s work revealed that the thymus alone could not prevent all self-reactive cells from escaping. Regulatory T cells provide a crucial second layer of protection, calming the immune system and preventing it from attacking the body’s own tissues. (Image: Wikimedia Commons)

Image count5 / 7
CNBCTV18 on Google

The Genetic Switch | Following this discovery, Mary Brunkow and Fred Ramsdell identified the FOXP3 gene, which controls the development and function of regulatory T cells. Mutations in this gene lead to severe autoimmune conditions in both animals and humans. Regulatory T cells, guided by FOXP3, act as safeguards, maintaining peripheral immune tolerance and ensuring the immune system does not turn against itself. Mutations in this gene also cause a severe autoimmune disease called IPEX in humans. (Image: Nobel Prize)

Image count6 / 7
CNBCTV18 on Google

How It Differs from Other Immune Mechanisms | This discovery differs from traditional immune responses in that its primary function is not to attack pathogens but to restrain harmful immune reactions. Conventional immune systems focus on identifying and eliminating foreign invaders such as bacteria, viruses, and tumor cells. In contrast, the system identified by the 2025 Nobel laureates introduces a layered mechanism: regulatory T cells actively suppress self-reactive T cells, maintaining a delicate balance between defense and self-preservation. This layered approach ensures the immune system can respond to threats without damaging the body itself. (Image: Canva)

Image count7 / 7
CNBCTV18 on Google

Opening New Medical Frontiers | These discoveries have opened new medical frontiers for treating autoimmune diseases, improving cancer therapies, and preventing complications after transplantations. Regulatory T cells are often found in cancerous tumors, where they may shield the tumor from immune attack. Researchers are exploring ways to overcome this protection. Understanding FOXP3 and regulatory T cells now allows scientists to design therapies that reprogram the immune system to fight cancer or reduce autoimmunity, offering hope for more precise and effective medical interventions. Scientists are also working on genetically modified versions of T cells to promote organ transplant tolerance—the body’s ability to accept foreign tissue from a donor. (Image: Canva)

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...